Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Aminopeptidase
    (3)
  • AChR
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

lta4 hydrolase

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    6
    TargetMol | Inhibitors_Agonists
SC-57461A
T21696423169-68-0
SC 57461A is a potent and specific leukotriene A4 hydrolase (LTA4H) inhibitor.
  • $35
In Stock
Size
QTY
SC-22716
SC 22716, SC22716
T28698262451-89-8
SC-22716 is an orally active leukotriene A4 (LTA4) hydrolase inhibitor.SC-22716 has potential anti-inflammatory activity and may be used in the study of inflammatory bowel disease and psoriasis.
  • $293
In Stock
Size
QTY
5(S),6(R)-DiHETE
T3765282948-88-7
5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in guinea pig lung membranes. It induces guinea pig ileum contraction with an ED50 value of 1.3 μM.
  • $2,570
10-14 weeks
Size
QTY
12-epi Leukotriene B4
12-epi Leukotriene B4
T3797083709-73-3
Leukotriene B4 (LTB4) compounds are produced by both enzymatic and non-enzymatic processes. The products of enzymatic origin, via Leukotriene A4 (LTA4) hydrolase, are stereospecifically 12(R). Non-enzymatic hydrolysis products are 50:50 mixtures at C-12, but are almost exclusively trans at C-6. Thus, the non-enzymatic hydrolysis product of LTA4 is 6-trans-12-epi LTB4. 12-epi LTB4 is an isomer which would not be expected to occur in either non-enzymatic hydrolysis products, or in the enzymatic products of LTA4 hydrolase. Compared to LTB4, 12-epi LTB4 has significantly reduced activity for the LTB4 receptor on human neutrophils (IC50 of 7.5 mM), and on guinea pig lung membranes with a (Ki of 4.7 mM). 12-epi LTB4 is an weak agonist at both the recombinant human BLT1 and BLT2 receptors, requiring approximately 10 mM for full activation of the receptor.
  • TBD
35 days
Size
QTY
Tosedostat
CHR-2797
T6301238750-77-1
Tosedostat (CHR-2797) is an orally bioavailable inhibitor of the M1 family of aminopeptidases with potential antineoplastic activity. Intracellularly converted into the poorly membrane-permeable active metabolite (CHR-79888), it inhibits puromycin-sensitive aminopeptidase (PuSA) and leukotriene A4 (LTA4) hydrolase. This inhibition in tumor cells may lead to amino acid deprivation, suppressed protein synthesis, increased proapoptotic protein Noxa levels, and ultimately, cell death.
  • $50
In Stock
Size
QTY
TargetMol | Inhibitor Sale
JNJ-40929837
T712831191044-42-4
JNJ-40929837 is an oral inhibitor of LTA4 hydrolase, which catalyzes LTB4 production.
  • $1,820
8-10 weeks
Size
QTY